TransMedics Group Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, TransMedics Group stock has a consensus rating of "Buy" and an average price target of $97.3. The average 1-year stock price forecast is 8.14% higher than the current stock price, while the lowest is $65 (-27.76%) and the highest is $125 (+38.92%).

Price Target: $97.3 (+8.14%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$65	$97.3	$97.5	$125
Change	-27.76%	+8.14%	+8.36%	+38.92%

Analyst Ratings

The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	7	7	6	6	6	6
Buy	2	2	2	2	2	2
Hold	2	2	3	3	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Jennings TD Cowen	TD Cowen	Buy Maintains $120	Buy	Maintains	$120	+33.36%	Sep 3, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Buy Reiterates $100 → $90	Buy	Reiterates	$100 → $90	+0.02%	Sep 2, 2026
Suraj Kalia Oppenheimer	Oppenheimer	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Aug 24, 2026
Thomas Stephan Stifel Nicolaus	Stifel Nicolaus	Hold Maintains $65	Hold	Maintains	$65	-27.76%	Aug 13, 2026
William Plovanic Canaccord Genuity	Canaccord Genuity	Buy Maintains $95	Buy	Maintains	$95	+5.58%	Aug 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

741.71M

from 605.49M

22.50%

from 605.49M

Revenue Next Year

874.74M

from 741.71M

17.93%

from 741.71M

EPS This Year

1.56

from 2.63

-40.65%

from 2.63

EPS Next Year

2.31

from 1.56

47.88%

from 1.56

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	30.26M	93.46M	241.62M	441.54M	605.49M	741.71M
Revenue Growth	18.03%	208.83%	158.53%	82.74%	37.13%	22.50%
Gross Profit	21.16M	65.27M	154.09M	262.08M	362.81M	436.38M
Gross Margin	69.92%	69.84%	63.77%	59.36%	59.92%	58.83%
Operating Income	-39.43M	-31.44M	-1.52M	37.50M	108.58M	90.59M
Net Income	-44.22M	-36.23M	-25.03M	35.46M	190.29M	51.99M
EPS	-	-	-	-	2.63	1.56
EPS Growth	-	-	-	-	160.10%	-40.65%
Forward PE	-	-	-	56.70	47.40	57.72
Free Cash Flow	-15.66M	-45.96M	-192.83M	-102.77M	94.00M	-9.70M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	753.0M
Avg	741.7M
Low	727.5M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	24.4%
Avg	22.5%
Low	20.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.72
Avg	1.56
Low	1.17

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-34.5%
Avg	-40.7%
Low	-55.6%